Home

Ingenieurwesen Aussehen Patois ara cell fachinformation Grenze Vergleichbar Texter

ARA-cell® 1000 mg Infusionslösung
ARA-cell® 1000 mg Infusionslösung

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche  und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with  Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties |  Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with  Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties |  Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

Anhang
Anhang

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche  und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

Nabilon | SpringerLink
Nabilon | SpringerLink

Regulatory T cells and myeloid-derived suppressor cells in metastatic renal  cell carcinoma: Modulation by sorafenib and sunitini
Regulatory T cells and myeloid-derived suppressor cells in metastatic renal cell carcinoma: Modulation by sorafenib and sunitini

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

Natalija Novak's research works | University of Bonn, Bonn (Uni Bonn) and  other places
Natalija Novak's research works | University of Bonn, Bonn (Uni Bonn) and other places

Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste

A proof of concept phase I/II pilot trial of LSD1 inhibition by  tranylcypromine combined with ATRA in refractory/relapsed AML patients not  eligible for intensive therapy. - Abstract - Europe PMC
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC

MATRIX / High-dose chemotherapy and autologous stem cell transplant or  consolidating conventional chemotherapy in primary CNS ly
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

HLA-B8 frequencies and the spread of agriculture in Europe. Adapted... |  Download Scientific Diagram
HLA-B8 frequencies and the spread of agriculture in Europe. Adapted... | Download Scientific Diagram

Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste

US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents

ARA-cell® | STADA
ARA-cell® | STADA

Informationen zur zweckmäßigen Vergleichstherapie
Informationen zur zweckmäßigen Vergleichstherapie

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

Identification of solubility-limited absorption of oral anticancer drugs  using PBPK modeling based on rat PK and its relevance to human -  ScienceDirect
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect

A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter  Phenotyping Cocktail With Adefovir, Sitagliptin
A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin

STADApharm
STADApharm

ARA-cell 100 mg/ml Konzentrat
ARA-cell 100 mg/ml Konzentrat

A proof of concept phase I/II pilot trial of LSD1 inhibition by  tranylcypromine combined with ATRA in refractory/relapsed AML patients not  eligible for intensive therapy. - Abstract - Europe PMC
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC